Despite an already strong run, Frencken Group Limited (SGX:E28) shares have been powering on, with a gain of 26% in the last thirty days. But the gains over the last month weren't enough to make shareholders whole, as the share price is still down 4.0% in the last twelve months.

Following the firm bounce in price, Frencken Group's price-to-earnings (or "P/E") ratio of 16.7x might make it look like a sell right now compared to the market in Singapore, where around half of the companies have P/E ratios below 13x and even P/E's below 8x are quite common. However, the P/E might be high for a reason and it requires further investigation to determine if it's justified.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

With earnings growth that's superior to most other companies of late, Frencken Group has been doing relatively well. It seems that many are expecting the strong earnings performance to persist, which has raised the P/E. If not, then existing shareholders might be a little nervous about the viability of the share price.

Check out our latest analysis for Frencken Group

SGX:E28 Price to Earnings Ratio vs Industry July 20th 2025

Keen to find out how analysts think Frencken Group's future stacks up against the industry? In that case, our free report is a great place to start.

Advertisement

What Are Growth Metrics Telling Us About The High P/E?

In order to justify its P/E ratio, Frencken Group would need to produce impressive growth in excess of the market.

Retrospectively, the last year delivered a decent 14% gain to the company's bottom line. However, this wasn't enough as the latest three year period has seen an unpleasant 37% overall drop in EPS. Accordingly, shareholders would have felt downbeat about the medium-term rates of earnings growth.

Looking ahead now, EPS is anticipated to climb by 11% each year during the coming three years according to the five analysts following the company. With the market only predicted to deliver 8.7% per annum, the company is positioned for a stronger earnings result.

In light of this, it's understandable that Frencken Group's P/E sits above the majority of other companies. Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.

The Final Word

The large bounce in Frencken Group's shares has lifted the company's P/E to a fairly high level. While the price-to-earnings ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of earnings expectations.

We've established that Frencken Group maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected. Right now shareholders are comfortable with the P/E as they are quite confident future earnings aren't under threat. It's hard to see the share price falling strongly in the near future under these circumstances.

A lot of potential risks can sit within a company's balance sheet. Take a look at our free balance sheet analysis for Frencken Group with six simple checks on some of these key factors.

If these risks are making you reconsider your opinion on Frencken Group, explore our interactive list of high quality stocks to get an idea of what else is out there.